Artesunate+Mefloquine Hydrochloride Tablet 600mg+750mg

Artesunate+Mefloquine Hydrochloride Tablet 600mg+750mg Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

• Artesunate+Mefloquine Hydrochloride Tablet 220mg+100mg
  
• Artesunate+Mefloquine Hydrochloride Tablet 600mg+750mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

•  a) Artesunate+Mefloquine Hydrochloride Tablet 220mg+100mg
  Each Film-coated tablet contains:
  Artesunate I.P.…………………………….100mg
  Mefloquine Hydrochloride IP…………….220mg
  Eq. to Mefloquine base ………………….200mg
  Excipients…………………………………. q.s.
  Colours: Titanium Dioxide IP
• b) Artesunate+Mefloquine Hydrochloride Tablet 600mg+750mg
  Each Film-coated tablet contains:
  Artesunate I.P.…………………………….600mg
  Mefloquine Hydrochloride IP…………….750mg
  Eq. to Mefloquine base ………………….700mg
  Excipients…………………………………. q.s.
  Colours: Quinoline Yellow

THERAPEUTIC INDICATIONS:

• Artesunate injection is used to treat severe malaria. This medicine is also used together with other medicines (eg, 8-aminoquinoline medicine) to treat severe malaria caused by Plasmodium oval or Plasmodium vivax. Artesunate belongs to a group of medicines known as antimalarials.

CAUTION & WARNING:

• CAUTION:
  Read enclosed leaflet before use.
  Keep medicine out of reach of children.
  SWALLOW WHOLE DO NOT CHEW OR CRUSH
  
  

STORAGE & DOSAGE:

• Storage: Protect form moisture at a temperature not exceeding 30˚C.Do not freeze. Keep the container tightly closed in order to protect from moisture.
  
• Dosage: As directed by the Physician

Introduction to Artesunate+Mefloquine Hydrochloride Tablet 600mg+750mg

Artesunate+Mefloquine Hydrochloride Tablet 600mg+750mg is a fixed-dose combination medication used in the treatment and prevention of malaria caused by Plasmodium falciparum, a parasite known for its resistance to many standard antimalarial therapies. This combination is a part of the artemisinin-based combination therapies (ACTs) recommended by the World Health Organization. While artesunate rapidly kills the parasite by generating reactive oxygen species, mefloquine ensures complete clearance and prevents recurrence. This dual action makes the tablet highly effective, particularly in malaria-endemic zones where chloroquine and other first-line drugs have failed.

 The demand for Artesunate+Mefloquine Hydrochloride Tablet 600mg+750mg is increasing globally, especially in African, Southeast Asian, and South American regions due to rising drug resistance and recurring outbreaks. Governments, NGOs, and international health organizations rely on reliable pharmaceutical exporters like Taj Pharma to procure this life-saving treatment in large volumes. The combination tablet is a cornerstone in national malaria control programs and public health procurement schemes.

In-depth Details for Importers, Exporters, and Global Buyers

Taj Pharma, a trusted name among Artesunate+Mefloquine Hydrochloride Tablet 600mg+750mg manufacturers in India, offers global buyers complete export support, making them an ideal partner for international tenders, public health missions, and pharmaceutical distributors. Their offering is not just limited to manufacturing; it includes a full suite of documentation and compliance support.

Importers receive all necessary regulatory documents, such as WHO-GMP certificate, EU-GMP, COPP (Certificate of Pharmaceutical Product), CTD Dossier, Product Registration Files, Stability Data, and Product Samples. Taj Pharma also assists in dossier compilation and technical support for regulatory submission in importing countries.

The product is available in customized packaging formats, including Alu-Alu blister packs and HDPE bottles. Taj Pharma ensures all packaging is tamper-proof and moisture-resistant, maintaining product stability in harsh climatic conditions. Multilingual labeling, barcodes, and serialization are provided per export market needs.

Shelf life of Artesunate+Mefloquine Hydrochloride Tablet 600mg+750mg is 36 months when stored under controlled room temperature below 25°C. The dosage form is an oral tablet, designed for ease of administration even in rural field settings.

Taj Pharma targets major malaria-prevalent countries and already exports this medication to nations such as Nigeria, Kenya, Uganda, Ethiopia, Myanmar, Cambodia, Bangladesh, Colombia, Peru, Ghana, Sudan, and others. Their efficient supply chain and strategic partnerships with global freight and clearance agents ensure quick and secure delivery to any corner of the world.

Why Taj Pharma is the Most Trusted Artesunate+Mefloquine Hydrochloride Tablet 600mg+750mg Manufacturer and Exporter

As a WHO-GMP certified Artesunate+Mefloquine Hydrochloride Tablet 600mg+750mg manufacturer in India, Taj Pharma is distinguished by its stringent manufacturing standards, international accreditations, and commitment to quality. Operating from its state-of-the-art manufacturing facility in Vapi, Gujarat, Taj Pharma complies with international regulatory norms and continually invests in technology and innovation.

Taj Pharma’s ability to deliver affordable pricing while ensuring unmatched product purity and consistency makes it the preferred supplier in competitive tenders and international public health contracts. Whether it’s a bulk procurement drive by a health ministry or a long-term NGO supply contract, Taj Pharma meets the highest expectations in cost efficiency and quality assurance.

The company’s global presence spans over 75 countries, backed by a strong distribution network, multilingual support team, and end-to-end supply chain assistance. Taj Pharma’s partnerships with humanitarian organizations, UN procurement channels, and medical relief missions further solidify its global reputation.

Top 20 countries where Taj Pharma exports Artesunate+Mefloquine Hydrochloride Tablet 600mg+750mg include: Nigeria, Kenya, Myanmar, Ethiopia, Ghana, Sudan, DR Congo, Mozambique, Zambia, Sierra Leone, Bangladesh, Cambodia, Laos, Vietnam, Peru, Colombia, Venezuela, Bolivia, Malawi, and Tanzania.

Technical Product Specification Table

📞 If you’re searching for the most dependable Artesunate+Mefloquine Hydrochloride Tablet 600mg+750mg manufacturer in India, look no further than Taj Pharma. With unmatched expertise, regulatory readiness, and global experience, Taj Pharma is the top choice for importers, NGOs, government contracts, and pharmaceutical distributors across continents.

📧 Contact Us Now
Email: info@tajpharma.com
📱 Phone: +91 84484 44095
📲 WhatsApp: +91 7400009975 / +91 7400009976
🌐 Website: www.tajpharmaindia.com

Top 20 FAQs 

Q1. What is Artesunate+Mefloquine Hydrochloride Tablet 600mg+750mg used for?
It is used for treating and preventing malaria caused by Plasmodium falciparum.

Q2. Can this medicine be used as prophylaxis?
Yes, it can be used in regions with chloroquine-resistant malaria strains.

Q3. Is it WHO-GMP approved?
Yes, Taj Pharma is a WHO-GMP approved manufacturer.

Q4. What are the side effects?
Nausea, dizziness, abdominal pain, diarrhea, and fatigue are common.

Q5. Can the product be customized for packaging?
Yes, Taj Pharma offers private labeling and multilingual packaging options.

Q6. What is the shelf life of this tablet?
It has a shelf life of 36 months.

Q7. What is the ideal storage condition?
Store below 25°C in a cool, dry environment.

Q8. Can I register this product in my country?
Yes, Taj Pharma provides CTD Dossier and full registration support.

Q9. Do you provide trial samples?
Yes, samples are provided upon request for evaluation and registration.

Q10. What is the shipping time for bulk orders?
15 to 30 days, depending on order volume and destination.

Q11. Is this product included in WHO guidelines?
Yes, it’s part of the WHO’s recommended ACT therapy.

Q12. Can Taj Pharma handle large-volume contracts?
Absolutely. The facility can handle both institutional and commercial bulk orders.

Q13. What are the dosing instructions?
Administered under physician supervision, dosage varies by age/weight.

Q14. Can it be co-administered with other drugs?
Doctor consultation is required before combining with other treatments.

Q15. Are pediatric versions available?
Yes, tailored doses/formulations for pediatric use are available upon request.

Q16. Is there risk of resistance?
Combination therapy reduces resistance, making it safer for long-term use.

Q17. What if vomiting occurs after taking the tablet?
If vomiting occurs within an hour, a second dose should be taken.

Q18. Is it safe in pregnancy?
Only under strict medical supervision. Always consult a doctor.

Q19. What is the export documentation provided?
WHO-GMP, COPP, CTD Dossier, Stability Data, and CoAs are included.

Q20. How to initiate a partnership with Taj Pharma?
Reach out via email or phone to begin a quotation and documentation process.